Follow The Filings

TWST Twist Bioscience Corporation

Health Care, filed as Twist Bioscience Corp (COMMON STOCK), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q3, sold by 1

  • 4 Owners
  • Max 3.8%
  • $1.1B
  • 1 new 1 add 1 reduce

In 2026 Q3 Henry Ellenbogen opened a position in Twist Bioscience, Polen Capital Management added, and Cathie Wood trimmed.

Who owns this now

Largest portfolio weights among holders, up to 3.8% (Cathie Wood, ARK Investment Management). Not free-float ownership.

  1. Cathie Wood Reduce 3.8%
  2. Farallon Capital Management 1.8%
  3. Henry Ellenbogen New 0.50%
  4. Polen Capital Management Add 0.17%

Who owns TWST

Sorted by value, long equity only, as of 2026 Q3.

History
Cathie Wood, ARK Investment Management 3.8% Reduce −25.3% 3,398,057 $657M History
Farallon Capital Management 1.8% Hold 2,136,400 $413M History
Henry Ellenbogen, Durable Capital Partners 0.50% New 0.50% 251,000 $49M History
Polen Capital Management 0.17%, was 0.05% Add +46.9% 81,226 $16M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by TWST's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TWST insider trades
  • None no insider bought on the open market
  • $5.6M sold by 3 insiders outside a trading plan
  • $112M sold by 6 insiders under 10b5-1 plans
  1. Paula Green SVP of Human Resources
    Sale
    — 20,429 shares 14% of stake
    Traded Nov 12 Filed Nov 16
  2. Emily M. Leproust CEO
    Planned sale
    $919K 4,548 shares at $202.15 0.8% of stake
    Traded Oct 5 Filed Oct 7
  3. Emily M. Leproust CEO
    Planned sale
    $131K 655 shares at $200.00 0.1% of stake
    Traded Oct 1 Filed Oct 5
  4. Emily M. Leproust CEO
    Planned sale
    $923K 5,203 shares at $177.38 0.8% of stake
    Traded Sep 24 Filed Sep 25
  5. Emily M. Leproust CEO
    Planned sale
    $56.3M 356,546 shares at $157.99 37% of stake
    Traded Sep 17 Filed Sep 21
  6. Emily M. Leproust CEO
    Planned sale
    $6.3M 41,570 shares at $151.98 5.1% of stake
    Traded Aug 25 Filed Aug 27
  7. Dennis Cho See Remarks
    Planned sale
    $1.8M 14,205 shares at $129.75 16% of stake
    Traded Aug 19 Filed Aug 21
  8. Patrick John Finn COO
    Planned sale
    $9.2M 78,355 shares at $117.64 27% of stake
    Traded Aug 18 Filed Aug 20
  9. Emily M. Leproust CEO
    Planned sale
    $2.5M 19,952 shares at $125.08 2.4% of stake
    Traded Aug 12 Filed Aug 14
  10. Emily M. Leproust CEO
    Planned sale
    $14.2M 113,318 shares at $125.16 12% of stake
    Traded Aug 10 Filed Aug 12
  11. Robert Chess Director
    Planned sale
    $2M 18,417 shares at $110.89 47% of stake
    Traded Aug 7 Filed Aug 11
  12. Dennis Cho See Remarks
    Planned sale
    $1.6M 14,205 shares at $109.75 14% of stake
    Traded Aug 5 Filed Aug 7
  13. Emily M. Leproust CEO
    Planned sale
    $1.8M 18,880 shares at $95.00 2.2% of stake
    Traded Jun 25 Filed Jun 26
  14. Dennis Cho See Remarks
    Planned sale
    $1.3M 14,205 shares at $89.75 12% of stake
    Traded Jun 24 Filed Jun 26
  15. Paula Green SVP of Human Resources
    Sale
    $2.1M 26,137 shares at $81.67 18% of stake
    Traded Jun 15 Filed Jun 17

Also filed in the last 12 months, not counted as buying or selling: 92 sales to cover taxes, 21 option exercises, 18 stock grants, and 2 gifts.

SEC filings

Recent issuer filings from EDGAR, 6 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
10-K
8-K 2.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G/A —

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $245.11M $312.97M $376.57M $459.43M
Gross profit * $89.73M $133.35M $191M $240.8M
Gross margin * 36.6% 42.6% 50.7% 52.4%
Net income -$204.62M -$208.73M -$77.67M -$130.2M
Net margin * -83.5% -66.7% -20.6% -28.3%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $424.26M $346.78M $332.97M $737.22M
Total non-current assets * $352.15M $267.55M $308.9M $384.58M
Total assets $0.776B $0.614B $0.642B $1.12B
Total current liabilities $73.32M $71.01M $91.41M $125.81M
Total non-current liabilities * $79.65M $70.63M $77.5M $107.98M
Total equity $623.43M $472.69M $472.96M $888.02M

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations -$142.47M -$64.09M -$47.63M -$41.43M
Cash from investing $50.61M -$3.07M -$24.76M -$53.09M
Cash from financing $0.911M $6.89M $28.54M $446.68M
Net change in cash -$90.98M -$60.15M -$43.71M $352.18M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf